In-center nocturnal hemodialysis: Another option in the management of chronic kidney disease

Clinical Journal of the American Society of Nephrology

Volumn 4, Issue 4, 2009, Pages 778-783

  Bugeja, Ann ^a   Dacouris, Niki ^b   Thomas, Alison ^b   Marticorena, Rosa ^b   McFarlane, Philip ^b,c   Donnelly, Sandra ^b,c   Goldstein, Marc ^b,c  

^a UNIVERSITY OF OTTAWA   (Canada)

^b ST MICHAEL'S HOSPITAL   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; ANTIHYPERTENSIVE AGENT; CALCIUM; ERYTHROPOIETIN; HEMOGLOBIN; IRON; PARATHYROID HORMONE; PHOSPHATE BINDING AGENT; PHOSPHORUS; RECOMBINANT ERYTHROPOIETIN; UREA; ANTIANEMIC AGENT; BIOLOGICAL MARKER;

ADULT; APPETITE; ARTICLE; CHRONIC KIDNEY DISEASE; CLINICAL ARTICLE; ENERGY; FEMALE; HEMODIALYSIS; HOME DIALYSIS; HUMAN; LONG TERM CARE; MALE; MUSCLE CRAMP; OUTCOME ASSESSMENT; PATIENT CARE; PRESCRIPTION; QUALITY OF LIFE; SLEEP; ATTITUDE TO HEALTH; BLOOD; CHRONIC DISEASE; CIRCADIAN RHYTHM; FEASIBILITY STUDY; HEALTH CARE QUALITY; HEALTH PERSONNEL ATTITUDE; KIDNEY DISEASE; METABOLISM; METHODOLOGY; MIDDLE AGED; NURSING; RENAL REPLACEMENT THERAPY; RETROSPECTIVE STUDY; TREATMENT OUTCOME; URINE;

ADULT; ALKALINE PHOSPHATASE; ANTIHYPERTENSIVE AGENTS; ATTITUDE OF HEALTH PERSONNEL; BIOLOGICAL MARKERS; CALCIUM; CHRONIC DISEASE; CIRCADIAN RHYTHM; FEASIBILITY STUDIES; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEMATINICS; HEMODIALYSIS UNITS, HOSPITAL; HEMOGLOBINS; HUMANS; IRON; KIDNEY DISEASES; MALE; MIDDLE AGED; PARATHYROID HORMONE; PHOSPHORUS; PROGRAM EVALUATION; QUALITY OF LIFE; RENAL DIALYSIS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 66449113370     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.05221008     Document Type: Article

References (24)

1. Collins AJ, Foley R, Herzog C, Chavers B, Gilbertson D, Ishani A, Kasiske B, Liu J, Mau LW, McBean M, Murray A, St Peter W, Xue J, Fan Q, Guo H, Li Q, Li S, Peng Y, Qiu Y, Roberts T, Skeans M, Snyder J, Solid C, Wang C, Weinhandl E, Zaun D, Zhang R, Arko C, Chen SC, Dalleska F, Daniels F, Dunning S, Ebben J, Frazier E, Hanzlik C, Johnson R, Sheets D, Wang X, Forrest B, Constantini E, Everson S, Eggers P, Agodoa L: Excerpts from the United States Renal Data System 2007 annual data report. Am J Kidney Dis 51[Suppl 1]: S1-320, 2008
2. Sarnak MJ, Levey AS, Schoolwerth AC, Coresh J, Culleton B, Hamm LL, McCullough PA, Kasiske BL, Kelepouris E, Klag MJ, Parfrey P, Pfeffer M, Raij L, Spinosa DJ, Wilson PW: Kidney disease as a risk factor for development of cardiovascular disease: A statement from the American Heart Association councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation 108: 2154-2169, 2003 (Pubitemid 37337595)
3. Gudex CM: Health-related quality of life in endstage renal failure. Qual Life Res 4: 359-366, 1995
4. McFarlane PA, Bayoumi AM, Pierratos A, Redelmeier DA: The quality of life and cost utility of home nocturnal and conventional in-center hemodialysis. Kidney Int 64: 1004-1011, 2003 (Pubitemid 37013836)
5. Laurent G, Charra B: The results of an 8 h thrice weekly haemodialysis schedule. Nephrol Dial Transplant 13[Suppl 6]: 125-131, 1998 (Pubitemid 28356706)
6. Yuen D, Richardson RM, Chan CT: Improvements in phosphate control with short daily in-center hemodialysis. Clin Nephrol 64: 364-370, 2005 (Pubitemid 41671888)
7. Ayus JC, Achinger SG, Mizani MR, Chertow GM, Furmaga W, Lee S, Rodriguez F: Phosphorus balance and mineral metabolism with 3h daily hemodialysis. Kidney Int 71: 336-342, 2007 (Pubitemid 46227093)
8. Mucsi I, Hercz G, Uldall R, Ouwendyk M, Francoeur R, Pierratos A: Control of serum phosphate without any phosphate binders in patients treated with nocturnal hemodialysis. Kidney Int 53: 1399-1404, 1998 (Pubitemid 28316904)
9. Chan CT, Floras JS, Miller JA, Richardson RM, Pierratos A: Regression of left ventricular hypertrophy after conversion to nocturnal hemodialysis. Kidney Int 61: 2235-2239, 2002 (Pubitemid 34539341)
10. Chan C, Floras JS, Miller JA, Pierratos A: Improvement in ejection fraction by nocturnal haemodialysis in end-stage renal failure patients with coexisting heart failure. Nephrol Dial Transplant 17: 1518-1521, 2002 (Pubitemid 34893298)
11. Chan CT, Harvey PJ, Picton P, Pierratos A, Miller JA, Floras JS: Short-term blood pressure, noradrenergic and vascular effects of nocturnal home hemodialysis. Hypertension 42: 925-931, 2003 (Pubitemid 37413732)
12. Chan CT, Jain V, Picton P, Pierratos A, Floras JS: Nocturnal hemodialysis increases arterial baroreflex sensitivity and compliance and normalizes blood pressure of hypertensive patients with end-stage renal disease. Kidney Int 68: 338-344, 2005 (Pubitemid 43181393)
13. Culleton BF, Walsh M, Klarenbach SW, Mortis G, Scott- Douglas N, Quinn RR, Tonelli M, Donnelly S, Friedrich MG, Kumar A, Mahallati H, Hemmelgarn BR, Manns BJ: Effect of frequent nocturnal hemodialysis vs conventional hemodialysis on left ventricular mass and quality of life. JAMA 298: 1291-1299, 2007
14. Yuen D, Pierratos A, Richardson RM, Chan CT: The natural history of coronary calcification progression in a cohort of nocturnal haemodialysis patients. Nephrol Dial Transplant 21: 1407-1412, 2006
15. Heidenheim AP, Muirhead N, Moist L, Lindsay RM: Patient quality of life on quotidian hemodialysis. Am J Kidney Dis 42[Suppl]: 36-41, 2003 (Pubitemid 36807681)
16. McPhatter LL, Lockridge RS Jr, Albert J, Anderson H, Craft V, Jennings FM, Spencer M, Swafford A, Barger T, Coffey L: Nightly home hemodialysis: Improvement in nutrition and quality of life. Adv Ren Replace Ther 6: 358-365, 1999
17. Brissenden JE, Pierratos A, Ouwendyk M, Roscoe JM: Improvements in quality of life with nocturnal hemodialysis [Abstract]. J Am Soc Nephrol 9: 168A, 1998
18. Ramkumar N, Beddhu S, Eggers P, Pappas LM, Cheung AK: Patient preference for in-center intense hemodialysis. Hemodial Int 9: 281-295, 2005
19. Nissenson AR, Swan SK, Lindberg JS, Soroka SD, Beatey R, Wang C, Picarello N, McDermott-Vitak A, Maroni BJ: Randomized, controlled trial of darbopoetin alfa for the treatment of anemia in hemodialysis patients. Am J Kidney Dis 40: 110-118, 2002
20. Centers for Medicare & Medicaid Services - Medicare Program: Changes to the Hospital Outpatient Prospective Payment System and Calendar Year 2005 Rates; Final Rule. 42 CFR Part 419. Fed Reg 69: 65681-66234, 2004
21. Pierratos A, McFarlane P, Chan CT: Quotidian dialysis: Update 2005. Curr Opin Nephrol Hypertens 14: 119-124, 2005
22. Kurella M, Hung AM, Tichy M, Hsu C, Chertow GM: Intermittent nocturnal in-center hemodialysis: UCSF-Mt Zion experience [Abstract]. J Am Soc Nephrol 13: 410A, 2002
23. Lindsay RM, Al-Hejaili F, Nesrallah G, Leitch R, Clement L, Heidenheim AP, Kortas C: Calcium and phosphate balance with quotidian hemodialysis. Am J Kidney Dis 42[Suppl]: 24-29, 2003
24. Al-Hejaili F, Kortas C, Leitch R, Heidenheim AP, Clement L, Nesrallah G, Lindsay RM: Nocturnal but not short hours quotidian hemodialysis requires an elevated dialysate calcium concentration. J Am Soc Nephrol 14: 2322-2328, 2003